New Coronavirus Neutralizing Antibody Rapid Test For Serum Plasma
|
2019-NCoV Neutralizing Antibody Rapid Test (Immunochromatography) Precautions
Intended UseThis kit is used to qualify the normal coronavirus (2019 ncov)
neutralizing antibody in human serum, plasma and whole blood
samples. Principle of Detection
This kit uses immunochromatography. The inspection card contains a
quality control line C, an inspection line T, and an inspection
line R, and the sample to be examined (serum / plasma / whole
blood) diffuses upward by the capillary action at the edge end.
S-rbd, which contains markers in the binding pad, associates with
the ACE2 protein immobilized in the NC membrane to detect the
signal at the T line position. When neutralizing antibody is
present in the sample, it is combined with the s-rbd antigen
labeled in the marker pad. Neutralizing antibody inhibits s-rbd and
ACE 2 binding, and signal values decrease. There was a negative
correlation between the neutralizing antibody content and the
signal value of the T line. The control line R and the quality
control line C should be colored regardless of the color of the T
line. Quality control line C is used for quality control, but if
the C line has no color, the test is disabled, so the sample must
be retested. Main ComponentsThe kit consists of a test card and a sample buffer. Storage Conditions and ValiditySave at 2 to 30 degrees Celsius, and the effective period is 12
months. Sample Requirements1 serum, plasma or whole blood samples. Test MethodPlease read the usage instructions before the test. Return all
reagents to room temperature before the test. Test should be done
at room temperature.
Interpretation of Test Results
Explanation of the test card 1.An invalid result: the quality control line (C line) reaction
line appears, the detection is invalid, and the retest should be
done. Limitation of Test Method
1.This kit is a qualitative test and is used only for in vitro
diagnosis. Product Performance Indicators 1. Specificity analysis 1.1Cross reaction: no interference was observed when the interference was tested for the following types of antibodies.
1.2 In order to evaluate the possibility of interferers, the following concentrations were added to the specified concentration samples. As a result, it was shown that various interferences did not interfere with the detection result of this reagent.
2.Clinical study: a novel test of the normal coronavirus (2019-ncov) IgG antibody test reagent (colloidal gold method) was carried out as a comparative reagent, and 120 positive and 300 samples were tested
Precautions1.This product is for in vitro diagnosis. Company profileZhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments. The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product Tags: New Coronavirus Neutralizing Antibody Rapid Test Serum Coronavirus Neutralizing Antibody Rapid Test Plasma neutralizing antibody test for covid-19 |
![]() |
COVID-19 Neutralizing Antibody Rapid Test Immunochromatography Storage Conditions |
![]() |
2019 NCoV Coronavirus Neutralizing Antibody Rapid Test Immunochromatography BfArm |
![]() |
CE Coronavirus Neutralizing Antibody Rapid Test Detection Card Sample Buffer |
![]() |
New Coronavirus Neutralizing Antibody Rapid Test For Serum Plasma |
![]() |
2019 Beta-Cobs Covid-19 Neutralizing Antibody Test Kit For Whole Blood |
![]() |
OEM ODM Covid Neutralizing Antibody Test Kit For Covid-19 |